146 related articles for article (PubMed ID: 31799467)
1.
Inturri R; Trovato L; Volti GL; Oliveri S; Blandino G
Heliyon; 2019 Nov; 5(11):e02891. PubMed ID: 31799467
[No Abstract] [Full Text] [Related]
2. Growth and adhesion to HT-29 cells inhibition of Gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination.
Inturri R; Stivala A; Furneri PM; Blandino G
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4943-4949. PubMed ID: 27981539
[TBL] [Abstract][Full Text] [Related]
3. Effect of
Toscano M; De Grandi R; Stronati L; De Vecchi E; Drago L
World J Gastroenterol; 2017 Apr; 23(15):2696-2704. PubMed ID: 28487606
[TBL] [Abstract][Full Text] [Related]
4. Microbiological characteristics of the probiotic strains B. longum BB536 and L. rhamnosus HN001 used in combination.
Inturri R; Stivala A; Blandino G
Minerva Gastroenterol Dietol; 2015 Dec; 61(4):191-7. PubMed ID: 26657925
[TBL] [Abstract][Full Text] [Related]
5. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains.
Schoster A; Kokotovic B; Permin A; Pedersen PD; Dal Bello F; Guardabassi L
Anaerobe; 2013 Apr; 20():36-41. PubMed ID: 23471038
[TBL] [Abstract][Full Text] [Related]
6. Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients.
Bonfrate L; Di Palo DM; Celano G; Albert A; Vitellio P; De Angelis M; Gobbetti M; Portincasa P
Eur J Clin Invest; 2020 Mar; 50(3):e13201. PubMed ID: 31960952
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.
Zhou JS; Pillidge CJ; Gopal PK; Gill HS
Int J Food Microbiol; 2005 Feb; 98(2):211-7. PubMed ID: 15681048
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic activities of some Bifidobacterium sp. strains isolated from resident infant gastrointestinal microbiota on Gram-negative enteric pathogens.
Delcaru C; Alexandru I; Podgoreanu P; Cristea VC; Bleotu C; Chifiriuc MC; Bezirtzoglou E; Lazar V
Anaerobe; 2016 Jun; 39():39-44. PubMed ID: 26921694
[TBL] [Abstract][Full Text] [Related]
10. Assessing inhibitory activity of probiotic culture supernatants against Pseudomonas aeruginosa: a comparative methodology between agar diffusion, broth culture and microcalorimetry.
Fredua-Agyeman M; Gaisford S
World J Microbiol Biotechnol; 2019 Mar; 35(3):49. PubMed ID: 30840154
[TBL] [Abstract][Full Text] [Related]
11. Use of Lactobacillus plantarum Strains as a Bio-Control Strategy against Food-Borne Pathogenic Microorganisms.
Arena MP; Silvain A; Normanno G; Grieco F; Drider D; Spano G; Fiocco D
Front Microbiol; 2016; 7():464. PubMed ID: 27148172
[TBL] [Abstract][Full Text] [Related]
12. Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro.
Zhou JS; Gopal PK; Gill HS
Int J Food Microbiol; 2001 Jan; 63(1-2):81-90. PubMed ID: 11205957
[TBL] [Abstract][Full Text] [Related]
13. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli.
Gopal PK; Prasad J; Smart J; Gill HS
Int J Food Microbiol; 2001 Aug; 67(3):207-16. PubMed ID: 11518430
[TBL] [Abstract][Full Text] [Related]
14. Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice.
Zhou JS; Shu Q; Rutherfurd KJ; Prasad J; Birtles MJ; Gopal PK; Gill HS
Int J Food Microbiol; 2000 May; 56(1):87-96. PubMed ID: 10857928
[TBL] [Abstract][Full Text] [Related]
15. Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients.
Lee DK; Park JE; Kim MJ; Seo JG; Lee JH; Ha NJ
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):237-44. PubMed ID: 25459995
[TBL] [Abstract][Full Text] [Related]
16. Bifidobacterium longum-fermented broccoli supernatant inhibited the growth of Candida albicans and some pathogenic bacteria in vitro.
Suido H; Miyao M
Biocontrol Sci; 2008 Jun; 13(2):41-8. PubMed ID: 18661679
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains.
Mogna L; Del Piano M; Deidda F; Nicola S; Soattini L; Debiaggi R; Sforza F; Strozzi G; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S29-32. PubMed ID: 22955353
[TBL] [Abstract][Full Text] [Related]
18. Influence of bovine lactoferrin on the growth of selected probiotic bacteria under aerobic conditions.
Chen PW; Ku YW; Chu FY
Biometals; 2014 Oct; 27(5):905-14. PubMed ID: 24916115
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Inhibition of Klebsiella pneumoniae by Lactobacillus delbrueckii Subsp. delbrueckii LDD01 (DSM 22106): An Innovative Strategy to Possibly Counteract Such Infections in Humans?
Mogna L; Deidda F; Nicola S; Amoruso A; Del Piano M; Mogna G
J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S136-S139. PubMed ID: 27741158
[TBL] [Abstract][Full Text] [Related]
20. Lactic acid bacteria as functional probiotic isolates for inhibiting the growth of Aspergillus flavus, A. parasiticus, A. niger and Penicillium chrysogenum.
Abbaszadeh S; Tavakoli R; Sharifzadeh A; Shokri H
J Mycol Med; 2015 Dec; 25(4):263-7. PubMed ID: 26597145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
